Search Results - "Springfeld C"

Neoadjuvante und adjuvante Therapie beim Pankreaskarzinom.

Alternate Title: Neoadjuvant and adjuvant treatment of pancreatic cancer.

Authors: Springfeld, C. Hackert, T. Jäger, D. et al.

Source: Der Chirurg. Aug2020, Vol. 91 Issue 8, p636-641. 6p.

209 (PB089) - Update from the ongoing phase 1/2 registrational trial of repotrectinib: results in TKI-naïve and TKI-pretreated patients with NTRK fusion-positive advanced solid tumors (TRIDENT-1).

Authors: Besse, B. Springfeld, C. Baik, C. et al.

Source: European Journal of Cancer. 2022 Supplement 1, Vol. 174, pS75-S76. 2p.

Fatal varicella in an immunocompromised adult associated with a European genotype E2 variant of varicella zoster virus

Authors: Springfeld, C. Sauerbrei, A. Filusch, A. et al.

Source: Journal of Clinical Virology. Jan2009, Vol. 44 Issue 1, p70-73. 4p.

Efficacy of Zenocutuzumab in NRG1 Fusion-Positive Cancer.

Authors: Schram, A. M. Goto, K. Kim, D.-W. et al.

Source: New England Journal of Medicine. 2/6/2025, Vol. 392 Issue 6, p566-576. 11p.

Repotrectinib in ROS1 Fusion-Positive Non-Small-Cell Lung Cancer.

Authors: Drilon, A. Camidge, D. R. Lin, J. J. et al.

Source: New England Journal of Medicine. 1/11/2024, Vol. 390 Issue 2, p118-131. 14p.

Targeted lentiviral vectors pseudotyped with the Tupaia paramyxovirus glycoproteins.

Authors: Enkirch, T Kneissl, S Hoyler, B et al.

Source: Gene Therapy. Jan2013, Vol. 20 Issue 1, p16-23. 8p.

Chemovirotherapy for head and neck squamous cell carcinoma with EGFR-targeted and CD/UPRT-armed oncolytic measles virus.

Authors: Zaoui, K Bossow, S Grossardt, C et al.

Source: Cancer Gene Therapy. Mar2012, Vol. 19 Issue 3, p181-191. 11p. 1 Diagram, 5 Graphs.

56P Multi-omic profiling in cholangiocarcinoma to enable scientific advancement within the DKFZ/NCT/DKTK MASTER study.

Authors: Nichetti, F. Korell, F. Schwab, M. et al.

Source: Annals of Oncology. 2024 Supplement 2, Vol. 35, pS234-S234. 1p.

1372P Repotrectinib in patients (pts) with NTRK fusion-positive (NTRK+) advanced solid tumors, including NSCLC: Update from the phase I/II TRIDENT-1 trial.

Authors: Solomon, B.J. Drilon, A. Lin, J.J. et al.

Source: Annals of Oncology. 2023 Supplement 2, Vol. 34, pS787-S788. 2p.

Association of perioperative use of statins, metformin and aspirin with recurrence after curative liver resection in patients with hepatocellular carcinoma: a propensity score matching analysis.

Authors: Khajeh, E. Aminizadeh, E. Moghadam, A. Dooghaie et al.

Source: HPB (1365-182X). 2024 Supplement 1, Vol. 26, pS206-S206. 1p.

PCR181 Health-Related Quality-of-Life of Patients Treated with Repotrectinib for Neurotrophic Tyrosine Receptor Kinase (NTRK)-Positive Advanced Solid Tumors: Results from TRIDENT-1.

Authors: Sherif, B. Besse, B. Solomon, B. et al.

Source: Value in Health. 2023 Supplement, Vol. 26 Issue 12, pS484-S484. 1p.

533P Efficacy and safety of entrectinib in patients with locally advanced/metastatic NTRK fusion-positive (NTRK-fp) solid tumours.

Authors: Bazhenova, L. Liu, S.V. Lin, J.J. et al.

Source: Annals of Oncology. 2021 Supplement 5, Vol. 32, pS598-S599. 2p.

80TiP Global phase III study of NUC-1031 plus cisplatin vs gemcitabine plus cisplatin for first-line treatment of patients with advanced biliary tract cancer (NuTide:121).

Authors: Knox, J.J. McNamara, M.G. Goyal, L. et al.

Source: Annals of Oncology. 2020 Supplement 4, Vol. 31, pS272-S273. 2p.

52MO A randomized phase II trial of durvalumab and tremelIMUmab with gemcitabine or gemcitabine and cisplatin compared to gemcitabine and cisplatin in treatment-naïve patients with CHolangio- and gallbladdEr Carcinoma (IMMUCHEC).

Authors: Vogel, A. Boeck, S. Waidmann, O. et al.

Source: Annals of Oncology. 2022 Supplement 7, Vol. 33, pS563-S563. 1p.

59TiP Phase III study of NUC-1031 + cisplatin vs gemcitabine + cisplatin for first-line treatment of patients with advanced biliary tract cancer (NuTide:121).

Authors: Knox, J. McNamara, M.G. Goyal, L. et al.

Source: Annals of Oncology. 2021 Supplement 5, Vol. 32, pS381-S381. 1p.

Neoadjuvant therapy for left-sided resectable pancreatic ductal adenocarcinoma: evidence-based shift or premature extrapolation?

Authors: Uzunoglu FG Springfeld C Peccerella T et al.

Source: Hepatobiliary surgery and nutrition [Hepatobiliary Surg Nutr] 2026 Feb 01; Vol. 15 (1), pp. 15. Date of Electronic Publication: 2026 Jan 19.

Publication Type: Editorial; Comment

Journal Info: Publisher: AME Publishing Company Country of Publication: China (Republic : 1949- ) NLM ID: 101600750 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2304-3881 (Print) Linking ISSN: 23043881 NLM ISO Abbreviation: Hepatobiliary Surg Nutr Subsets: PubMed not MEDLINE

Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer.

Authors: O'Reilly EM Wainberg ZA Hendifar AE et al.

Corporate Authors: O'Reilly EM Wainberg ZA Hendifar AE et al.

Source: The New England journal of medicine [N Engl J Med] 2026 Jul 23; Vol. 395 (4), pp. 325-337. Date of Electronic Publication: 2026 May 31.

Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study; Comparative Study

Journal Info: Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE

Efficacy and Tolerability of Zenocutuzumab in Advanced NRG1 Fusion-Positive Cholangiocarcinoma: Results From the eNRGy Phase II Trial.

Authors: Cleary JM Springfeld C Arnold D et al.

Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2026 Jul 01, pp. JCO2503128. Date of Electronic Publication: 2026 Jul 01.

Publication Type: Journal Article

Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Hierarchical classification of immune cell transcriptomes at population-scale.

Authors: Beltz C Qiu Z Sadowski L et al.

Source: BioRxiv : the preprint server for biology [bioRxiv] 2026 Jun 21. Date of Electronic Publication: 2026 Jun 21.

Publication Type: Journal Article; Preprint

Journal Info: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

Clinical implications and biomarkers in the PACT-21 CASSANDRA trial.

Authors: Neoptolemos JP Springfeld C Öhlund D et al.

Source: Lancet (London, England) [Lancet] 2026 May 02; Vol. 407 (10540), pp. 1684-1685.

Publication Type: Letter

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE; In Process